BioSpectrum Asia is a unique, integrated B2B media platform of print, digital, online and events. It engages its readers from Life-Sciences industry (Pharma, Biotech & Medtech) across Asia pacific region on a Daily/Fortnightly/Monthly through its media products and services. BioSpectrum Asia started, as first Business life-science industry magazine with an objective to create a platform for growing Asia-pacific life sciences industry and is today the largest distributed Pan-Asia Life-Sciences industry magazine. The magazine is published, printed and distributed from Singapore by Cyber Media (Singapore) Pte Limited.
About Print magazine - Print edition is distributed monthly across Asia-pacific region covering pharma, biotech and medtech featuring News, articles, interviews, policies, products, events and issues impacting the industry in the regions.
About Digital magazine - Digital magazine is crisp, online, and easy to use, new age media which picks up an issue, segment or country every fortnightly covering the impact it has on the Asia Pacific life-sciences industry. It is delivered on 10th and the 26th of every month subscribers’ desktop to read it online or download for reading it at their convenience
About Portal - www.biospectrumasia.com   is a portal updated daily providing rich content for life sciences industry in Asia Pacific region. Easy navigation by country (Key countries in Asia Pacific region) and by sector (Pharma, Biotech and Medical devices) makes it interesting for the readers to get on to relevant information quickly.

CRO Asia © is a premium online media platform targeting pharmaceutical outsourcing industry namely contract research and manufacturing organizations (CROs and CMOs) based in Asia-Pacific regions. 
 
CRO Asia's unique and innovative partnering approach is to present a wide variety of contract service providers in Asia-Pacific to a highly specialized audience of scientists, professionals and decision makers in pharmaceutical industry. Our objective is to forge potential collaborations and strategic partnerships between those two parties by using our unique marketing tools and quality communication services. 
 
For more information, please visit us at http://www.croasia.net

General Biologic is a business intelligence and professional services firm focused on China’s biotechnology, pharmaceutical, and healthcare industries. We provide our clients with information, analysis, and advice enabling confident and informed decision making. Our offerings include information products such as our monthly publication- the China Pharmaceutical & Biotechnology Monthly, our recently launched SOURCE China pharmaceutical data service, and in-depth sector-specific reports covering areas including vaccines, molecular diagnostics, retail pharmacies, and others. We also provide our clients, which range from mid-size biotechnology companies to MNC pharma, with bespoke management consulting and advisory services focusing exclusively on the healthcare and pharmaceutical sectors in China. The GB team is made up of Western and Chinese professionals with backgrounds in medicine, life-science, and finance who have deep familiarity with the China healthcare and pharmaceutical business landscape.

Now in its 26th year, GEN retains its position as the most widely read biotechnology publication around the globe. GEN's international purview includes applied research through commercialization. Editorial content includes regulatory, strategic alliances and collaborations, clinical trials, corporate profiles, in-depth interviews with leaders in industry, academia, and government, instructive tutorials in drug discovery and bioprocessing to enhance research results, and new products that enable significant advances in bioscience R&D. Genetic Engineering & Biotechnology News (GEN), the only high-frequency publication dedicated to biotech news, was introduced in 1981, as the first biotechnology trade publication. GEN is now the most widely read bionews publication worldwide. GEN's unique news editorial mandate is the entirety of the bioproduct life cycle, from early-stage R&D, to applied research and bioprocess, through to commercialization, including marketing and regulatory. GEN is the only publication with this mandate, covering the entirety of commercial bioscience: biopharmaceuticals, bio-agriculture, chemicals and enzymes, and environmental markets, and emerging biosciences including biodefense, bioenergy, and nanobiotechnology. GEN has from the beginning fused industry, academia and government, to foster industry collaborations and agreements.

Outsourcing2india, the International publication brought out every month to promote the futuristic and ongoing business of OUTSOURCING to India from US, Europe and Asia Pacific.

Outsourcing2india contains up-to-date information on current outsourcing trends in USA, Europe and Asia both for the buyers and service providers of outsourcing. It includes in-depth articles, features, interviews and write-ups on IT outsourcing, Mfg outsourcing, Technology outsourcing, Software Development, BPO, ITES, Call / Contact centers, Off shoring / Near shoring, Business continuity planning, Disaster recovery and extensive coverage of International outsourcing conferences / seminars held worldwide - all sourced from International outsourcing analysts, domain experts, professional consultants and news agencies around the world.